Venus Concept Inc. (VERO) Stock Analysis
DELISTED 2026
What happened to Venus Concept Inc. (VERO) stock?
Venus Concept Inc. (VERO) no longer trades on public markets. It was delisted in April 2026. The figures below are historical and are not a current quote.
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Venus Concept Inc. (VERO) trades at $0.311. Venus Concept Inc. develops and commercializes minimally invasive and non-invasive medical aesthetic and hair restoration technologies. The company's diverse product portfolio caters to dermatological and cosmetic procedures globally. Sector: Healthcare.
Last analyzed: May 10, 2026Analyst Coverage for VERO: VERO does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates VERO against Healthcare peers across nine fundamental dimensions and assigns a neutral fundamental signal based on the underlying data.
VERO: 2/2 scored disciplines lean bearish. Dominant signal: Seth Klarman bearish.
How is this calculated? →Venus Concept Inc. (VERO) Healthcare & Pipeline Overview
Venus Concept Inc. is a medical technology company specializing in minimally invasive and non-invasive aesthetic and hair restoration technologies. Its diverse product portfolio, including Venus Legacy, Venus Versa, and ARTAS iX, serves a global market, positioning it as a player in the medical aesthetics industry.
What Is the Investment Thesis for VERO?
Venus Concept Inc. presents a compelling investment case based on its innovative product portfolio and growing presence in the medical aesthetics market. The company's diverse range of devices caters to a broad spectrum of aesthetic needs, driving revenue growth. A gross margin of 64.4% indicates strong pricing power and efficient cost management. However, a significant profit margin of -92.8% raises concerns about profitability and operational efficiency. Key growth catalysts include expanding into new geographic markets and introducing innovative products. Potential risks include intense competition and regulatory hurdles. Investors should closely monitor the company's ability to improve profitability and capitalize on growth opportunities.
Based on FMP financials and quantitative analysis
VERO Key Highlights
Gross Margin of 64.4% demonstrates strong pricing power in the medical aesthetics market.
- Profit Margin of -92.8% indicates significant challenges in achieving profitability.
- The company's product portfolio includes a diverse range of aesthetic device platforms, such as Venus Legacy, Venus Versa, and Venus Viva.
- Venus Concept operates internationally, expanding its market reach beyond the United States.
- The company's ARTAS iX robotic system represents a technological advancement in hair restoration.
Who Are VERO's Competitors?
VERO is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| ZBH Zimmer Biomet Holdings, Inc. | $100.72 | -0.02% | $19.5B | 78 |
| BSX Boston Scientific Corporation | $52.01 | +3.05% | $77.3B | 80 |
| ISRG Intuitive Surgical, Inc. | $391.80 | -1.49% | $138B | 94 |
| CNVIF Conavi Medical Corp. | $0.13 | -1.19% | $11.4M | 66 |
| VPTDF VentriPoint Diagnostics Ltd. | $0.07 | -4.02% | $13.8M | 62 |
| LHDX Lucira Health, Inc. | $0.45 | +0.00% | $18.4M | 64 |
| PLSM PLSM | $3.01 | +4.88% | $19.6M | 60 |
| PYNKF Perimeter Medical Imaging AI, Inc. | $0.27 | -1.08% | $24.6M | 73 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are VERO's Key Strengths?
Innovative product portfolio of aesthetic devices.
- Established global distribution network.
- Strong brand reputation in the medical aesthetics market.
- Proprietary technology in key product lines.
What Are VERO's Weaknesses?
Significant net losses and negative profit margin.
- High debt levels.
- Dependence on third-party distributors in some markets.
- Limited financial resources for marketing and R&D.
What Could Drive VERO Stock Higher?
Launch of new aesthetic device platforms targeting specific dermatological conditions.
- Expansion of the global distribution network to reach new markets.
- Increased investment in research and development to drive innovation.
What Are the Key Risks for VERO?
Financial-distress signal — its Altman Z-Score of -9.85 sits in the distress zone (elevated bankruptcy risk).
- Intense competition from established players in the medical aesthetics market.
- Regulatory hurdles and compliance requirements for medical devices.
- Economic downturns affecting consumer spending on aesthetic treatments.
- Technological advancements rendering existing products obsolete.
What Are the Growth Opportunities for VERO?
- Expansion into Emerging Markets: Venus Concept Inc. has the opportunity to expand its presence in emerging markets, such as Asia-Pacific and Latin America, where demand for aesthetic treatments is rapidly growing. These markets offer significant growth potential due to their large populations and increasing disposable incomes. By establishing strategic partnerships and distribution networks, Venus Concept can capitalize on this growing demand and increase its global market share. This expansion could contribute significantly to revenue growth within the next 3-5 years.
- Development of New Products and Technologies: Investing in research and development to create innovative aesthetic devices and technologies is crucial for Venus Concept Inc.'s long-term growth. By introducing new products that address unmet needs in the market, the company can attract new customers and retain existing ones. Focus areas could include advanced skin rejuvenation technologies, non-invasive body contouring solutions, and personalized aesthetic treatments. Successful product launches can drive revenue growth and enhance the company's competitive position.
- Strategic Acquisitions and Partnerships: Venus Concept Inc. can pursue strategic acquisitions and partnerships to expand its product portfolio, geographic reach, and technological capabilities. Acquiring complementary businesses or partnering with leading medical institutions can provide access to new markets, technologies, and expertise. These strategic moves can accelerate growth and enhance the company's competitive advantage in the medical aesthetics industry. Potential targets could include companies with innovative technologies or strong distribution networks.
- Increased Focus on Direct-to-Consumer Marketing: Venus Concept Inc. can enhance its brand awareness and drive sales by increasing its focus on direct-to-consumer marketing initiatives. This includes leveraging social media platforms, online advertising, and educational campaigns to reach potential customers directly. By educating consumers about the benefits of its products and services, the company can generate demand and drive traffic to its partner clinics. A strong direct-to-consumer marketing strategy can increase brand loyalty and drive revenue growth.
- Leveraging AI and Machine Learning for Personalized Treatments: Integrating artificial intelligence (AI) and machine learning (ML) into its aesthetic devices can enable Venus Concept Inc. to offer personalized treatments tailored to individual patient needs. AI-powered diagnostic tools can analyze skin conditions and recommend optimal treatment parameters, resulting in improved outcomes and patient satisfaction. By leveraging AI and ML, Venus Concept can differentiate its products and attract customers seeking personalized aesthetic solutions. This technological advancement can drive revenue growth and enhance the company's competitive position.
What Are VERO's Competitive Advantages?
- Proprietary Technology: Venus Concept Inc. possesses proprietary technology in its aesthetic device platforms, providing a competitive edge.
- Established Brand Reputation: The company has built a reputation for innovation and quality in the medical aesthetics market.
- Global Distribution Network: Venus Concept Inc. has established a global distribution network, enabling it to reach customers worldwide.
- Diverse Product Portfolio: The company's diverse product portfolio caters to a broad range of aesthetic needs, reducing reliance on any single product.
What Does VERO Do?
Venus Concept Inc., headquartered in Toronto, Canada, is a medical technology company focused on developing, commercializing, and delivering minimally invasive and non-invasive medical aesthetic and hair restoration technologies and related services. The company's journey began with a vision to innovate the aesthetic treatment landscape, offering advanced solutions for various dermatological and cosmetic needs. Its product portfolio includes a range of aesthetic device platforms, such as Venus Legacy, designed for non-invasive dermatological and surgical procedures; Venus Versa, a multi-application device for aesthetic and cosmetic procedures; and Venus Viva, a portable fractional RF system for skin resurfacing. Additionally, Venus Concept offers Venus Fiore for treating medical conditions, Venus Bliss for non-invasive lipolysis, Venus Glow for skin appearance improvement, and NeoGraft for advanced hair restoration. The company also provides Venus Velocity and Venus Epileve for hair removal, and ARTAS iX, a robotic system for hair follicle extraction and implantation. Venus Concept serves a global market, providing its technologies to medical practitioners and aesthetic clinics worldwide.
What Products and Services Does VERO Offer?
- Develops minimally invasive and non-invasive medical aesthetic devices.
- Commercializes aesthetic and hair restoration technologies.
- Offers a range of aesthetic device platforms, including Venus Legacy, Venus Versa, and Venus Viva.
- Provides solutions for hair removal, permanent hair reduction, and hair restoration.
- Offers the ARTAS iX robotic system for hair follicle extraction and implantation.
- Delivers related services to support its technology offerings.
How Does VERO Make Money?
- Sells aesthetic device platforms to medical practitioners and aesthetic clinics.
- Generates revenue from the sale of consumables and service contracts.
- Provides training and support services to customers.
- Expands market reach through strategic partnerships and distribution networks.
What Industry Does VERO Operate In?
The medical aesthetics industry is experiencing substantial growth, driven by increasing demand for minimally invasive and non-invasive cosmetic procedures. This growth is fueled by an aging population, rising disposable incomes, and a growing awareness of aesthetic treatments. Venus Concept Inc. operates in a competitive landscape that includes companies offering similar aesthetic devices and services. The company's success depends on its ability to differentiate its products through innovation, clinical efficacy, and strong marketing strategies.
Who Are VERO's Key Customers?
- Medical practitioners, including dermatologists and plastic surgeons.
- Aesthetic clinics and medical spas.
- Hair restoration specialists.
- Hospitals and healthcare facilities.
Company Profile
Venus Concept Inc. operates in the Medical - Devices industry within the Healthcare sector. It is headquartered in Toronto, CA. The company is led by CEO Rajiv Kanishka Liyanaarchchie De Silva. VERO has traded publicly since 2017.
Key Financial Metrics
Return on assets is -75.7%, showing how much profit it generates from its asset base. A current ratio of 0.90 means current liabilities exceed short-term assets, a liquidity point worth watching.
Financial Health
Venus Concept Inc.'s Piotroski F-Score is 4/9, a 9-point checklist of profitability, leverage and efficiency — a middling fundamental profile. Its Altman Z-Score of -9.85 places it in the distress zone, a signal of elevated financial risk.
Forward Outlook
Wall Street analysts project Venus Concept Inc. revenue of about $65.8M for fiscal 2026, with EPS near $-5.01.
VERO Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis · FY 2024
Bull Case vs Bear Case
Bull Case
- Innovative product portfolio of aesthetic devices.
- Established global distribution network.
- Strong brand reputation in the medical aesthetics market.
- Proprietary technology in key product lines.
Bear Case
- Significant net losses and negative profit margin.
- High debt levels.
- Dependence on third-party distributors in some markets.
- Limited financial resources for marketing and R&D.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · August 2026
VERO Latest News
No recent news available for VERO.
Leadership: Rajiv Kanishka Liyanaarchchie De Silva
CEO
Rajiv Kanishka Liyanaarchchie De Silva serves as the CEO of Venus Concept Inc. His background encompasses leadership roles within the medical technology sector, focusing on strategic growth and operational efficiency. De Silva's experience includes driving innovation and commercialization of medical devices. He is responsible for managing the company's overall strategic direction, overseeing product development, and expanding its global market presence. His leadership aims to strengthen Venus Concept's position as a key player in the medical aesthetics industry.
Track Record: Under De Silva's leadership, Venus Concept Inc. has focused on expanding its product portfolio and increasing its global market share. Key milestones include the launch of new aesthetic device platforms and strategic partnerships to enhance distribution channels. His strategic decisions aim to improve the company's financial performance and drive long-term growth, focusing on innovation and customer satisfaction.
Common Questions About VERO (Healthcare)
What happened to Venus Concept Inc. (VERO) stock?
Venus Concept Inc. (VERO) no longer trades on public markets. It was delisted in April 2026. The figures below are historical and are not a current quote.
Can I still buy VERO shares?
No. VERO stopped trading on public markets in April 2026, so the shares are not available through a broker. Anything you see quoted for VERO elsewhere is historical data, not a live market.
Are the figures on this page current?
No. Every number here is the last value recorded before VERO stopped trading. Nothing on this page updates, and none of it is a current quote.
Why does this page still exist?
Because people still search for what happened to Venus Concept Inc.. An archived profile that states the delisting plainly is more useful than a dead link — provided it is labelled as history, which is what this page does.
What does Venus Concept Inc. do?
Venus Concept Inc. is a medical technology company that develops, commercializes, and delivers minimally invasive and non-invasive medical aesthetic and hair restoration technologies. Its product portfolio includes a range of aesthetic device platforms, such as Venus Legacy, Venus Versa, and Venus Viva, which are used for various dermatological and cosmetic procedures.
What do analysts say about VERO stock?
Analyst coverage of Venus Concept Inc. (VERO) is limited, reflecting its small market capitalization and volatile financial performance. The consensus view suggests caution due to the company's negative profit margin and high debt levels. However, some analysts recognize the potential for growth driven by its innovative product portfolio and expansion into emerging markets.
What are the main risks for VERO?
Venus Concept Inc. faces several key risks, including intense competition from established players in the medical aesthetics market, regulatory hurdles and compliance requirements for medical devices, and economic downturns affecting consumer spending on aesthetic treatments. The company's significant net losses and high debt levels also pose financial risks.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Financial data is based on the most recent available information.
- Market analysis is based on industry reports and expert opinions.
- This dossier is for informational purposes only and does not constitute investment advice.